MedEnvision has successfully partnered with Smile Invest to accelerate its global growth strategy in the MedTech industry.
Information on the Target
MedEnvision is a rapidly expanding Belgian MedTech company specializing in orthopedics. Established in 2012, the company is dedicated to supporting surgeons, their teams, and hospitals worldwide by optimizing efficiency, redistributing personnel meaningfully, improving staff ergonomics, and managing infections in operating rooms. MedEnvision has gained a reputation as a trusted partner in the orthopedic field and has been offering patented products such as the Gripper® and EsySuit® in 26 countries since its commercial launch in 2015.
With impressive annual revenue growth and a strong profitability record, MedEnvision is currently experiencing significant momentum in the U.S. market. The company intends to expand its product range, broaden the applications of its existing portfolio, and increase its geographical reach, driven by its commitment to innovation and excellence in healthcare solutions.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Belgium
The MedTech industry in Belgium is characterized by its dynamic growth and innovative capabilities, stemming from a robust healthcare system and extensive research initiatives. Bel
Similar Deals
Cochlear, Resmed, Nyxoah’s Chairman and Management → Nyxoah SA
2025
Fidelity Management & Research Company → Agomab Therapeutics NV
2023
Smile Invest
invested in
MedEnvision
in 2024
in a Other deal